You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

EBV-CTL

Showing 1 - 25 of 412
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Post-transplant Lymphoproliferative Disease, Transplant-Related Hematologic Malignancy Trial in London (Autologous EBV-CTL

Active, not recruiting
  • Post-transplant Lymphoproliferative Disease
  • Transplant-Related Hematologic Malignancy
  • Autologous EBV-CTL transduced with vector SFG-CNA12
  • +2 more
  • London, United Kingdom
  • +1 more
Jan 19, 2022

Neuroblastoma Trial in Houston (EBV specific CTLs)

Active, not recruiting
  • Neuroblastoma
  • EBV specific CTLs
  • Houston, Texas
    Texas Children's Hospital
Feb 2, 2022

Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma Trial in Houston (autologous CAR.CD30 EBV specific-CTLs)

Active, not recruiting
  • Hodgkin's Lymphoma
  • Non-Hodgkin's Lymphoma
  • autologous CAR.CD30 EBV specific-CTLs
  • Houston, Texas
  • +1 more
Feb 4, 2022

Serologically Active Adult Systemic Lupus Erythematosus Trial in Nantes, Paris (Autologous EBV specific CTL infusion)

Terminated
  • Serologically Active Adult Systemic Lupus Erythematosus
  • Autologous EBV specific CTL infusion
  • Nantes, France
  • +2 more
Mar 24, 2022

EBV Lymphoma, Post-transplant Lymphoproliferative Disease (PTLD) Trial in Switzerland (Donor-derived ex-vivo expanded EBV Tscm

Not yet recruiting
  • EBV Lymphoma
  • Post-transplant Lymphoproliferative Disease (PTLD)
  • Donor-derived ex-vivo expanded EBV Tscm CTL
  • Basel, Switzerland
  • +7 more
Jan 25, 2023

Epstein-Barr Virus (EBV) Infections, Lymphoproliferative Disorders, EBV+ Associated Lymphoma Trial (tabelecleucel)

Available
  • Epstein-Barr Virus (EBV) Infections
  • +11 more
  • tabelecleucel
  • (no location specified)
Feb 15, 2022

Hodgkin Disease, Non-Hodgkin Lymphoma, Severe Chronic Active Epstein Barr Virus Trial in Houston (MABEL CTLs, Cyclophosphamide,

Recruiting
  • Hodgkin Disease
  • +5 more
  • MABEL CTLs
  • +2 more
  • Houston, Texas
  • +1 more
Jan 13, 2023

Multiple Sclerosis Trial in Nantes (Cellular therapy with EBV specific autologous CTL infusion)

Recruiting
  • Multiple Sclerosis
  • Cellular therapy with EBV specific autologous CTL infusion
  • Nantes, France
    University Hospital
Jan 27, 2021

Lymphoma, Hodgkin's Disease, Relapse Trial in Houston (TGFbeta resistant LMP-specific CTLs)

Active, not recruiting
  • Lymphoma
  • +3 more
  • TGFbeta resistant LMP-specific CTLs
  • Houston, Texas
  • +1 more
Dec 8, 2021

Extranodal NK/T-cell Lymphoma Trial in Korea, Republic of (VT-EBV-N, Placebo)

Recruiting
  • Extranodal NK/T-cell Lymphoma
  • VT-EBV-N
  • Placebo
  • Busan, Korea, Republic of
  • +7 more
Apr 28, 2022

Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications,

Completed
  • Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease (EBV+ PTLD)
  • +2 more
  • tabelecleucel
  • La Jolla, California
  • +26 more
Mar 24, 2021

Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications,

Recruiting
  • Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD)
  • +4 more
  • tabelecleucel
  • Duarte, California
  • +70 more
Jun 23, 2022

Acute Lymphocytic Leukemia, Lymphoma Trial in New York (Biological/Genetically Modified T cells, Cyclophosphamide-based chemo)

Active, not recruiting
  • Acute Lymphocytic Leukemia
  • Lymphoma
  • Biological/Genetically Modified T cells
  • Cyclophosphamide-based chemotherapy
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 3, 2023

Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Houston (autologous or syngeneic PBTLs and EBV-CTLs)

Active, not recruiting
  • Non-Hodgkin Lymphoma
  • Chronic Lymphocytic Leukemia
  • autologous or syngeneic PBTLs and EBV-CTLs
  • Houston, Texas
  • +1 more
Feb 6, 2022

Epstein-Barr Virus (EBV)-Associated Diseases, EBV+ Lymphoproliferative Disease With Primary Immunodeficiency (PID LPD), EBV+

Recruiting
  • Epstein-Barr Virus (EBV)-Associated Diseases
  • +13 more
  • Tabelecleucel
  • Los Angeles, California
  • +39 more
Nov 9, 2022

Epstein-Barr Virus Infections, Adenovirus, Cytomegalovirus Infections Trial in Milwaukee (Cytotoxic T Lymphocytes)

Completed
  • Epstein-Barr Virus Infections
  • +2 more
  • Cytotoxic T Lymphocytes
  • Milwaukee, Wisconsin
    Medical College of Wisconsin
Oct 21, 2021

Viral Infections After HSCT Trial in Washington (VSTs)

Active, not recruiting
  • Viral Infections After HSCT
  • VSTs
  • Washington, District of Columbia
    Childrens National Medical Center
Aug 30, 2022

Viral Infection Trial in Washington, Houston (CMV/AdV /EBV/BKV specific T cells)

Recruiting
  • Viral Infection
  • CMV/AdV /EBV/BKV specific T cells
  • Washington, District of Columbia
  • +1 more
Aug 6, 2021

Nasopharyngeal Carcinoma Trial in Worldwide (autologous EBV specific Cytotoxic T cells, combination IV gemcitabine and IV

Active, not recruiting
  • Nasopharyngeal Carcinoma
  • autologous EBV specific Cytotoxic T cells
  • combination IV gemcitabine and IV carboplatin (AUC2)
  • Duarte, California
  • +29 more
Mar 5, 2021

CMV Viremia, CMV Trial in São Paulo (Lymphocyte infusion (ImmuneCellVir-I))

Recruiting
  • CMV Viremia
  • CMV
  • Lymphocyte infusion (ImmuneCellVir-I)
  • São Paulo, SP, Brazil
    Hospital Israelita Albert Einstein
Aug 21, 2023

Epstein-Barr Virus Infections, Cytomegalovirus Infections, Adenovirus Trial in New York (Rapidly generated virus specific T

Not yet recruiting
  • Epstein-Barr Virus Infections
  • +3 more
  • Rapidly generated virus specific T (R-MVST) cells
  • New York, New York
    Columbia University Irving Medical Center
Feb 18, 2022

Nasopharyngeal Carcinoma Trial in Guangzhou (Sintilimab, Capecitabine)

Recruiting
  • Nasopharyngeal Carcinoma
  • Guangzhou, Guangdong, China
    Department of Nasopharyngeal Carcinoma, Sun Yat-sen University C
May 5, 2022

Immunodeficiency for Severe Epstein-Barr Virus Infection

Recruiting
  • Epstein-Barr Virus Infections
  • Immunodeficiency
    • Shanghai, Shanghai, China
      Children's Hospital of Fudan University
    Mar 21, 2022

    EBV-associated Hemophagocytic Lymphohistiocytosis, EBV Infection Trial in Beijing (EBV-TCR-T cells)

    Recruiting
    • EBV-associated Hemophagocytic Lymphohistiocytosis
    • EBV Infection
    • EBV-TCR-T cells
    • Beijing, Beijing, China
      Chinese PLA General Hospital
    Nov 12, 2023

    CMV Infection, EBV Infection, Stem Cell Transplant Trial (Virus specific T cells)

    Not yet recruiting
    • CMV Infection
    • +2 more
    • Virus specific T cells
    • (no location specified)
    Oct 4, 2023